Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × Rocuronium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Renal Insufficiency, Chronic 2 Prostatic Neoplasms 2 Uterine Prolapse 1 Urinary Tract Infections 1 Urinary Bladder Neoplasms 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Skin Sympathetic Nerve Activity During General Anesthesia in Patients Undergoing Breast Cancer Surgery 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Pulmonary Arterial Hypertension 1 Pneumonia 1 Pain 1 Neutropenia 1 Neuromuscular Blockade 1 Muscle Hypotonia 1 Migraine Disorders 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Melanoma 1 Lung Neoplasms 1 Leiomyoma 1 Intraabdominal Infections 1 Intestinal Obstruction 1 Influenza, Human 1

Interventions

Cisplatin 147 Fluorouracil 124 Paclitaxel 116 Radiotherapy 113 Oxaliplatin 81 Docetaxel 66 Carboplatin 61 Irinotecan 56 Leucovorin 54 pembrolizumab 53 Capecitabine 52 Radiation 43 Esophagectomy 40 Surgical Procedures, Operative 39 Drug Therapy 31 Cetuximab 24 Neoadjuvant Therapy 23 Nivolumab 22 Bevacizumab 21 Trastuzumab 19 camrelizumab 18 S 1 (combination) 17 Magnetic Resonance Spectroscopy 17 Chemoradiotherapy 17 Albumin-Bound Paclitaxel 16 Epirubicin 14 Blood Specimen Collection 14 tislelizumab 13 Taxes 13 Gemcitabine 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02320734 2016-09-19

DEPTH

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 4 Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡